A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
{{output}}
Introduction: The protein-protein interaction PD1/PD-L1 is an important immune checkpoint and several recently approved monoclonal antibodies show promising anti cancer activities in the clinical practice. However, only a small p... ...
